RapidArc for highly targeted Tumor Treatment
RapidArc radiation technology is the latest innovation in the rapidarc radiation therapy treatment for cancer. It replaces the static field intensity modulated radiotherapy (IMRT) treatments. RapidArc modulates the radiation for high conformity while rotating the machine around the patient. It rotates four times faster than conventional IMRTs.
RapidArcÛªs precision to deliver exact amount of radiation with complete control of ON and OFF as per the tumorÛªs motion, makes it highly useful and beneficial. This feature makes it greatly suitable for the treatment of head and neck, lung and prostate tumors, with the patient having to spend lesser time on the treatment bed.
RapidArc radiotherapy delivers highly targeted treatments to tumors that are moving, especially the lung tumors. In India, Yashoda Hospitals Hyderabad has pioneered the use of RapidArc radiotherapy technology for treatment of tumors of the brain, head and neck.
The Cancer Institute at Yashoda Hospitals Hyderabad phased out the use of ‘static-field’ intensity modulated radiotherapy (IMRT) treatments and replaced them with RapidArc for the treatment of tumors. In single and multiple rotations, the RapidArc machine provides radiotherapy treatments to the cancer patients.
Speed and precision of radiotherapy makes RapidArc highly beneficial for cancer patients. For the patient, it is not just the speedy treatment, but also the little time spent on the treatment bed makes a big difference. At Yashoda Hospitals, for the last six years, RapidArc has been very successful in the treatment of brain, head and neck tumors.
Yashoda Hospitals extends the benefit of RapidArc Radiotherapy Treatment to the poor and underprivileged sections of the society on pro bono basis. The less privileged of the society, who cannot afford advanced radiotherapy are provided RapidArc treatments for brain, head and neck tumors.
Yashoda Cancer Institute is a renowned Centre of Excellence in India for the treatment of different types of cancer. The Institute caters to the treatment needs of 10,000+ new cancer patients of India and other countries.